Several NIH institutes showcase programs, innovations and opportunities to the AASLD membership at this informative event. Representatives of the NCI, NIDDK, NIAID and NIAAA will present areas of mutual interest to the institute and AASLD membership, including liver cancer, NASH, viral hepatitis and alcohol use disorder. This is a unique opportunity to learn more about interagency collaboration and funding opportunities.
Patient and caregiver education, and transition to care are important aspects for hospital discharge. At this informative program, experts will review multidisciplinary strategies to optimize discharge planning and share innovative models of outpatient care in liver disease, including empowering patients and caregivers, decreasing risk factors and the incidence of hospital readmissions, and reducing costs.
In the world's poorest nations, the appalling loss of life from easily treated or preventable illnesses represents a moral tragedy. This year's President's Choice Lecture explores potential strategies to correct this inequity, including collaborative partnerships among medical professionals, ways to accurately measure the impact of global disease management efforts and the innovative solutions necessary to accomplish this great task.
Nonalcoholic steatohepatitis has become a leading indication for liver transplantation in the United States and worldwide. At this symposium, faculty will review pre-transplant evaluation and assessment of comorbid conditions in these patients, early and long-term challenges after transplantation, patterns of recurrence of the disease and potentially preventive strategies.
DESCRIPTION The practice of Hepatology is largely consultative in nature, whether evaluating outpatients referred for a variety of abnormal liver enzyme findings or diagnosing and managing critically-ill patients within a team of internists, hospitalists, residents, intensivists, and other healthcare providers. On any given day, a hepatologist will be confronted with complex patients and dizzying differential diagnoses to be methodically considered. The aim of this course is to provide insights about state-of-the-art consultative Hepatology attendees that can be applied to daily practice.
Aynur Unalp‐Arida, Constance E. Ruhl – 9 November 2019
Seonghwan Hwang, Yong He, Xiaogang Xiang, Wonhyo Seo, Seung‐Jin Kim, Jing Ma, Tianyi Ren, Seol Hee Park, Zhou Zhou, Dechun Feng, George Kunos, Bin Gao – 9 November 2019
Review steps to develop programs to eradicate HCV in the U.S. at this program. Speakers will address the current state of screening, novel models to engage more patients into therapy and the current state of access to HCV therapeutics, including generics. They will contrast U.S. efforts to eradicate HCV with programs from around the world.
Recent advances in liver bio-engineering have led to multiple in vitro culture systems that duplicate many complex cell-cell interactions of the intact liver. This symposium will highlight recent advances in this field, show current use of ex-vivo, 3D multicellular culture systems as probes of liver function and disease and update the progress toward the generation of the bio-artificial liver.
The Career Development Workshop is designed for hepatologists in the early career stage. Participants will explore how to maximize career opportunities in basic and clinical research, and will discuss potential sources of research funding for each pathway. They will also review an array of career pathways in both academic and community practice, and possible rewards and challenges hepatologists may encounter.